Xcout Intel
Artiria Medical
Artiria Medical is a medical technology company founded in 2019 and headquartered in Borex, Switzerland. The company develops cutting-edge technologies that empower catheters and guidewires to enable precise micromotion deep inside brain arteries.
Subscribe to see Artiria Medical’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Artiria Medical at a glance
Artiria Medical is a medtech company headquartered in Switzerland. Its most recent funding round, Series A2, raised $3.2M in February 2024. Xcout tracks 2 named people at Artiria Medical, including Guillaume Petit-Pierre (CEO and Co-Founder).
Artiria Medical leadership
- Guillaume Petit-PierreCEO and Co-Founder
- Marc BoersCOO and Co-Founder
Artiria Medical funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A2 | $3.2M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Artiria Medical competitors
A few of Artiria Medical's closest competitors — see the full list of competitors and alternatives →
Brightflow Medical is an innovative medical technology startup located in Paris, France, dedicated to developing cardiovascular medical devices and therapeutic solutions.
Aleva Neurotherapeutics is a Swiss company that designs, manufactures, and commercializes Deep Brain Stimulation (DBS) devices. Spun off from the Swiss Federal Institute of Technology, its objective is to improve treatments for Parkinson's disease.
Cyban is an Australian medical technology company founded in 2019 and based in Melbourne, Victoria. The company specializes in developing a non-invasive, continuous brain and tissue oxygen monitoring device designed to help prevent brain injury. It operates as a private entity and has completed a Series A funding round.
STENTiT is a medical device spin-off company from the Eindhoven University of Technology located at the High Tech Campus in Eindhoven, focusing on the development of regenerative medical implants.
INBRAIN Neuroelectronics develops graphene-based brain-computer interface (BCI) platforms and AI-driven neurotherapeutics designed to decode and modulate neural signals. The company serves patients with brain disorders and neurological conditions, such as Parkinson's disease, by providing real-time, personalized autonomous therapy.
Get Artiria Medical's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Artiria Medical in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access